Clinical Trial Update: Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Anakinra for futile reperfusion after endovascular treatment in acute ischemic stroke; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Stroke Acute, Endovascular Treatment | Phase 2 | Status: NOT_YET_RECRUITING